Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93175 citas

 
 
<< anterior 21 a 40 de 89 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Lee DSH, Markwardt S, Goeres L, Lee CG, Eckstrom E, Williams C, Fu R, Orwoll E, Cawthon PM, Stefanick ML, Mackey D, Bauer DC, Nielson CM. Statins and physical activity in older men. The Osteoporotic Fractures in Men Study. JAMA Intern Med 2014;174:1263-70. [Ref.ID 97621]
22. Cita con resumen
Grados D, Martínez-Morillo M, Holgado S, Erra A. Bisfosfonatos intravenosos en la enfermedad ósea de Paget: mayor riesgo de efectos secundarios. Med Clin (Barc) 2014;142:469-70. [Ref.ID 97553]
23. Cita con resumen
Anónimo. Advertisement medicine to treat chronic lymphocytic leukemia gets FDA approval. DIA Daily 2014:13 de febrero. [Ref.ID 97514]
24. Cita con resumen
Finegold JA, Manisti CH, Goldacre B, Barron AJ, Francis DP. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. European Journal of Preventive Cardiology 2014;21:464-74. [Ref.ID 97504]
25. Cita con resumen
Joy TR, Monjed A, Zou GY, Hegele RA, McDonald ChG, Mahon JL. N-of-1 (single-patient) trials for statin-related myalgia. Ann Intern Med 2014;160:301-10. [Ref.ID 97263]
26. Cita con resumen
Ebrahim S, Taylor FC, Brindle P. Statins for the primary prevention of cardiovascular disease. BMJ 2014;348:g280. [Ref.ID 97254]
27. Cita con resumen
Anónimo. Simeprevir (Olysio) for chronic hepatitis C. Med Lett Drugs Ther 2014;56:1-2. [Ref.ID 97179]
28. Cita con resumen
Mansi I, Frei CR, Pugh MJ, Makris U, Mortensen EM. Statins and musculoskeletal conditions, arthropathies, and injuries. JAMA Intern Med 2013;173:1318-26. [Ref.ID 95869]
29. Cita con resumen
Kelley BKJ. FDA approves new cholesterol-cutting combination drug. Journal Watch 2013:6 de mayo. [Ref.ID 95324]
30.Tiene citas relacionadas
Grundy SM. Statin discontinuation and intolerance: the challenge of lifelong therapy. Ann Intern Med 2013;158:562-3. [Ref.ID 95207]
31.Tiene citas relacionadas Cita con resumen
Zhang H, Plutzky J, Skentzos S, Morrison F, Mar P, Shubina M, Turchin A. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med 2013;158:526-34. [Ref.ID 95205]
32. Cita con resumen
Anónimo. Agomélatine: bilan des effets indésirables. Prescrire 2013;33:26-8. [Ref.ID 94677]
33. Cita con resumen
Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, Guidoni CM, de Lyra Jr DP, Pilger D, Duzanski J, Tettamanti M, Cruciol-Souza JM, Gaeti WP, Cuman RKN. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol 2012;68:1667-76. [Ref.ID 94168]
34. Cita con resumen
Boonen S, Reginster J-Y, Kaufman J-M, Lippuner K, Zanchetta J, Langdahl B, Rizzoli R, Lipschitz S, Dimai HP, Witvrouw R, Eriksen E, Brixen K, Russo L, Claessens F, Papanastasiou P, Antunez O, Su G, Bucci-Rechtweg C, Hruska J, Incera E, Vanderschueren D, Orwoll E. Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med 2012;367:1714-23. [Ref.ID 93959]
35. Cita con resumen
Anónimo. Statins and ciclosporin. Increased risk of statin-related adverse events including myopathy. New Zealand. WHO Pharmaceuticals Newsletter 2012;4:12. [Ref.ID 93680]
37. Cita con resumen
Anónimo. Pitavastatina. CADIME: Informe de Evaluación 2012:Marzo. [Ref.ID 93157]
38. Cita con resumen
Maningat P, Breslow JL. Needed: pragmatic clinical trials for statin-intolerant patients. N Engl J Med 2011;365:2250-1. [Ref.ID 91966]
39. Cita con resumen
Roehr B. Vaccines rarely cause adverse events, Institute of Medicine finds. BMJ 2011;343:d5538. [Ref.ID 91897]
40.Tiene citas relacionadas Cita con resumen
Carvajal A, García-Ortega P, Sáinz M, Velasco V, Salado I, Martín Arias LH, Eiros JM, Pérez Rubio A, Castrodeza J. Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting. Vaccine 2011;29:519-22. [Ref.ID 89853]
Seleccionar todas
 
<< anterior 21 a 40 de 89 siguiente >>